Migraine
📧 Sign up to get email alerts when something new happens for Migraine.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-03-18FDA Approved: DEPAKOTE SPRINKLES — Supplemental Application (AbbVie Inc.)
FDA approved AbbVie's supplemental application for Depakote Sprinkles (divalproex sodium).
-
FDA approval · 2024-02-15FDA Approved: DIHYDROERGOTAMINE MESYLATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for dihydroergotamine mesylate by Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2024-02-13FDA Approved: ELETRIPTAN HYDROBROMIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Eletriptan Hydrobromide from Teva Pharmaceuticals USA, Inc. This action updates the approved…
-
CLINICAL_TRIALS trial_result · 2024-02-08Clinical Trial Update: A Study With Lu AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments [Phase 2]
Phase 2 trial update for Lu AG09222 in adults with migraine who did not respond to prior preventive treatments has completed with posted res…
-
CLINICAL_TRIALS trial_result · 2024-02-08Clinical Trial Update: Tricaprilin Phase 2 Pilot Study in Migraine [Phase 2]
Phase 2 pilot study update for tricaprilin in migraine has been completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: Improving Health Outcomes of Migraine Patients Who Present to the Emergency Department [NA]
This document reports the completion and posted results of a NYU Langone Health-sponsored clinical trial evaluating health outcomes for migr…
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study [Phase 4]
Phase 4 open-label study assessing the long-term safety and tolerability of a migraine therapy in migraine patients. Results were posted in …
-
CLINICAL_TRIALS trial_result · 2024-02-05Clinical Trial Update: Onabotulinum Dose Comparison in Chronic Migraine Superior to 100 Units? [Phase 3]
Phase 3 trial evaluating whether higher doses of onabotulinumtoxinA are superior to 100 units for chronic migraine; the study is terminated.
-
FDA approval · 2024-02-01FDA Approved: BUTALBITAL AND ACETAMINOPHEN — Original Application (QUAGEN PHARMACEUTICALS LLC)
FDA approves an original ANDA for Butalbital and Acetaminophen from Quagen Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: "Follow the Sutures". A New Procedure for Injection of Botulinum Toxin for Chronic Migraine [Phase 2]
Phase 2 trial evaluating a new botulinum toxin injection procedure for chronic migraine has completed with results posted.
-
EMA safety_alert · 2024-01-26Precautionary measures to address potential risk of neurodevelopmental disorders in children born to men treated with valproate medicines
EMA safety precautionary measures advise restricting valproate use in men prior to conception due to possible risk of neurodevelopmental dis…
-
FDA approval · 2024-01-18FDA Approved: TOPIRAMATE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Topiramate from Zydus Lifesciences Limited. The action updates the product labeling and may expa…
-
CLINICAL_TRIALS trial_result · 2024-01-10Clinical Trial Update: RELAXaHEAD for Headache Patients (Phase II) [NA]
Clinical trial update for RELAXaHEAD in headache patients (Phase II) has completed with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-01-09Clinical Trial Update: Imaging the Migraine Brain Pre- and Post-Erenumab [Phase 4]
Phase 4 trial evaluating imaging of the migraine brain before and after erenumab completion with posted results.
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: Efficacy and Safety of Tx360® Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine [Phase 3]
Phase 3 trial evaluating Tx360 transnasal sphenopalatine ganglion block for chronic migraine has been completed, reporting on efficacy and s…
-
FDA approval · 2024-01-04FDA Approved: TROKENDI XR — Supplemental Application (Supernus Pharmaceuticals, Inc.)
The FDA approved a supplemental application for TROKENDI XR (topiramate) filed by Supernus Pharmaceuticals, Inc., updating the product's lab…
-
FDA approval · 2024-01-04FDA Approved: TOPIRAMATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Topiramate from Aurobindo Pharma Limited under an ANDA for an already approved generic product.
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: Safety and Tolerability of Frovatriptan to Prevention of Menstrually Associated Migraine (MAM) Headaches [Phase 3]
Phase 3 trial update assessing safety and tolerability of frovatriptan for preventing menstrually associated migraine (MAM) headaches.
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: A Controlled Trial to Investigate the Efficacy and Safety of Frovatriptan to Prevent Menstrual Migraine [Phase 3]
A Phase 3 controlled trial evaluated frovatriptan for preventing menstrual migraine; study completed.
-
FDA approval · 2023-12-27FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for divalproex sodium from Aurobindo Pharma Limited under an ANDA.
-
FDA approval · 2023-12-15FDA Approved: BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE — Supplemental Application (Amneal Pharmaceuticals of New York, LLC)
The FDA approved a supplemental application for Amneal's fixed-dose combination product of butalbital, aspirin, caffeine and codeine phospha…
-
CLINICAL_TRIALS trial_result · 2023-12-14Clinical Trial Update: Safety and Efficacy Trial of BHV3000 (Rimegepant) 75 mg for the Acute Treatment of Migraine [Phase 3]
Phase 3 trial update for BHV3000 (rimegepant) 75 mg in the acute treatment of migraine has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-08Clinical Trial Update: Oral Contraceptive Pill Compared With Vitamin E in Women With Migraine [Phase 3]
Phase 3 trial comparing an oral contraceptive pill with Vitamin E in women with migraine and menstrual migraine.
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: Comparison of Efficacy Between Combination of Amitriptyline-propranolol and Pizotifen for Migraine Prophylaxis. [Phase 2]
A Phase 2 clinical trial comparing amitriptyline-propranolol vs pizotifen for migraine prophylaxis; status is unknown.
-
FDA approval · 2023-12-05FDA Approved: TOPIRAMATE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approves an original abbreviated application for Topiramate from Upsher-Smith Laboratories, establishing a generic formulation of the an…